EnVen Energy Corporation’s $325 Million High-Yield Notes Offering

Davis Polk advised EnVen Energy Corporation in connection with a Rule 144A/Regulation S offering of $325 million aggregate principal amount of its 11.000% senior secured second-lien notes due 2023 through its wholly owned subsidiaries Energy Ventures GoM LLC and EnVen Finance Corporation. The notes are guaranteed on a senior secured second-priority basis by EnVen and […]

Ingersoll-Rand Global Holding Company Limited $1.15 Billion Senior Notes Offering

Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with an SEC-registered offering of senior notes by Ingersoll-Rand Global Holding Company Limited. The offering consisted of $300 million aggregate principal amount of 2.900% notes due 2021, $550 million aggregate principal amount of 3.750% notes due 2028 and $300 million […]

Sprint Corporation’s $1.5 Billion High Yield Notes Offering

Simpson Thacher represented the underwriters, led by J.P. Morgan Securities LLC, in connection with the public offering by Sprint Corporation (“Sprint”) of $1.5 billion aggregate principal amount of its 7.625% Notes due 2026. The offering was upsized from $1 billion. The net proceeds from the offering were used for general corporate purposes. Sprint is a […]

Bynder’s $49.1 Million Acquisition of Webdam

Willkie Farr & Gallagher advised Bynder in the deal Bynder, a global leader in digital asset management acquired Shutterstock’s digital asset management business, known as Webdam (NYSE:SSTK) for $49.1 million. The acquisition brings together digital asset management leaders from EMEA and North America to create a global organization offering marketing and creative teams with cloud-based […]

Clayton, Dubilier & Rice’s Acquisition of a Majority Interest in American Greetings

Debevoise & Plimpton LLP served as legal advisor, and Barclays, Deutsche Bank Securities, Citizens Capital Markets, ING Financial Markets LLC, Bank of America Merrill Lynch, HSBC Securities (USA) Inc., Sumitomo Mitsui Financial Group, and KeyBanc Capital Markets served as financial advisors to CD&R in the transaction. Jones Day served as legal advisor, and Centerview Partners […]

Motus GI Holdings’ $18 Million Initial Public Offering

Lowenstein represented medical device company Motus GI Holdings, Inc., in an $18 million IPO involving the sale of 3.5 million shares priced at $5 per share. Shares started trading on February 14, 2018. Piper Jaffray and Oppenheimer & Co. are underwriting the offering. Motus specializes in colonoscopy-related medical technology designed to enhance procedural quality and […]

Quintana Energy Services’ $92 Million Initial Public Offering

Vinson & Elkins advised Quintana Energy Services Inc. (QES) in connection with its initial public offering of 9,259,259 shares of its common stock at $10.00 per share. The offering closed on February 13, 2018. Quintana Energy Services Inc. (QES) is a growth-oriented provider of diversified oilfield services to leading onshore oil and natural gas exploration […]

Snowflake Computing’s $263 Million Round Funding

Cooley advised Snowflake Computing, a data warehouse provider, on raising a $263 million Series E led by Iconiq Capital, Altimeter Capital and newcomer Sequoia Capital. With this round of funding, Snowflake’s pre-money valuation is $1.5 billion. Partners Mark Tanoury and Seth Gottlieb led the Cooley team advising Snowflake on the transaction. The funding round also […]

Applied-Cleveland’s Acquisition of Encompass Energy Services and Perennial Environmental Services

Simpson Thacher represented Applied-Cleveland Holdings, a First Reserve portfolio company, in connection with its acquisition of both Encompass Energy Services and Perennial Environmental Services. Financial details of the transactions were not disclosed. Applied-Cleveland is a leading provider of inspection and integrity management services for energy infrastructure assets in North America. The company, led by Randy […]

RA Pharmaceuticals’ $58 Million Common Stock Offering

Goodwin advised RA Pharmaceuticals on the deal Ra Pharmaceuticals, Inc. (NASDAQ: RARX) executed the pricing of an underwritten public offering of 8,400,000 shares of its common stock at a public offering price of $6.00 per share, before underwriting discounts. Ra Pharma also granted the underwriters a 30-day option to purchase up to an additional 1,260,000 […]